| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maze Therapeutics, Inc. (MAZE) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 1 sell. MAZE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.47M | $114.89M | - | |
| CFO | 325.0K | $8.35M | - | |
| CEO | 100.0K | $2.57M | - | |
| Other | 36.6K | $941.0K | -7,500 | |
| Dir | 36.0K | $924.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2025 | Scheller Richard H90 | Director | Sell | 20,744 | $22.37 | $464,034.98 | -100% | +70.8% | - |